Delcath Systems DCTH Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies

Madrigal Pharmaceuticals, Inc.MDGL

——

Other financials

Income statement

See full

Revenue$25.0M+26.3%

Gross profit$21.3M+25.5%

Operating income-$1.6M-355%

Net income-$1.1M-200%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$41.3M+223%

Total debt$907.0K-10.7%

Total equity$112.7M+40.5%

Total assets$124.8M+43.0%

Cash flow

See full

Operating cash flow$857.0K-61.1%

CapEx$570.0K+307%

Free cash flow$287.0K-86.1%

Valuation

See full

Market cap$425.31M-11.8%

Enterprise value$384.91M-18.2%

P/E120.6×—

P/S4.7×-4.3×

Profitability

See full

Gross margin86%+1.1pp

Operating margin-118.1%-56.8pp

Net margin1.5%+0.8pp

FCF margin21.2%+15.2pp

Returns & leverage

See full

Return on equity1.9%+1.0pp

Debt / equity0×0.0×

Current ratio11.2×-4.7×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's share based compensation arrangement by share based payment award options exercisable number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Delcath Systems's share based compensation arrangement by share based payment award options exercisable number?: Delcath Systems (DCTH) reported share based compensation arrangement by share based payment award options exercisable number of $5.42M in Q1 2026.
How has Delcath Systems's share based compensation arrangement by share based payment award options exercisable number changed year-over-year?: Delcath Systems's share based compensation arrangement by share based payment award options exercisable number increased by 39.8% year-over-year, from $3.87M to $5.42M.